The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly recognised, not only in infants, but also in older adults (aged ≥65 years). Advances in knowledge of the structural biology of the RSV surface fusion glycoprotein have revolutionised RSV vaccine development by p...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Lancet infectious diseases Ročník 18; číslo 10; s. e295 - e311
Hlavní autoři:	Mazur, Natalie I, Higgins, Deborah, Nunes, Marta C, Melero, José A, Langedijk, Annefleur C, Horsley, Nicole, Buchholz, Ursula J, Openshaw, Peter J, McLellan, Jason S, Englund, Janet A, Mejias, Asuncion, Karron, Ruth A, Simões, Eric AF, Knezevic, Ivana, Ramilo, Octavio, Piedra, Pedro A, Chu, Helen Y, Falsey, Ann R, Nair, Harish, Kragten-Tabatabaie, Leyla, Greenough, Anne, Baraldi, Eugenio, Papadopoulos, Nikolaos G, Vekemans, Johan, Polack, Fernando P, Powell, Mair, Satav, Ashish, Walsh, Edward E, Stein, Renato T, Graham, Barney S, Bont, Louis J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Ltd 01.10.2018 Elsevier B.V Elsevier Limited
Témata:	Adults Antibodies, Monoclonal - immunology Antibodies, Viral - immunology Antigens Candidates Children Clinical trials COVID-19 vaccines Disease prevention Global Health Glycoproteins Humans Immunoglobulins Immunology Infants Infections Infectious diseases Medical research Monoclonal antibodies Mutation Nanoparticles Older people Proteins Respiratory syncytial virus Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus Vaccines - immunology Vaccine development Vaccines Viruses World Health Organization United States > US
ISSN:	1473-3099, 1474-4457, 1474-4457
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!